Betaville Intelligence

UNCOOKED ALERT: Aurinia Pharmaceuticals said to ... - Part 6

Thursday, 13 January 2022, 7:42 pm

It's been a while since there has been a fresh bid rumour about Aurinia, the US-listed biopharmaceutical company that featured several times on Betaville late last year.

But STAT - a specialist US-based healthcare publication - has just set tongues wagging.

According to STAT, US-listed drugs giant Biogen is working with bankers at Goldman Sachs on potential acquisitions and Aurinia Pharmaceuticals is on the list of targets alognside BioHaven Pharmaceuticals and Amlyx Pharmaceuticals. Below is a link to the STAT piece:..


Register for free to see rest of this article and all public articles from Betaville

Login / Register

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Login to join the conversation